🔴 10x Genomics is trading 4.28% down with no clear catalyst identified

10x Genomics is trading 4.28% down at $68.55, with no clear company-specific announcement identified to explain the November 2 move.

• The company is scheduled to report third-quarter results after the close on November 5; that upcoming report does not establish a cause for the decline.
• Major U.S. indexes were higher, while Reuters reported technology stocks steadied as markets rebounded; that context does not explain the stock’s opposite-direction move.
• No trading volume was provided, so activity level cannot be assessed.